For the purpose of this chapter, the following definitions shall apply unless the context clearly indicates or requires a different meaning.
SYNTHETIC CANNABINOID. Any laboratory- created compound that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog containing a cannabinoid receptor agonist, such as:
(1) JWH-007 (1-pentyl-2-methyl-3-(1- naphthoyl)indole);
(2) JWH-015 ((2-Methyl-1-propyl-1H- indol-3-yl)-1-naphthalenylmethanone);
(3) JWH-018 (1-pentyl-3-(1- naphthoyl)indole);
(4) JWH-019 (1-hexyl-3-(naphthalen-1- oyl)indole);
(5) JWH-073 (naphthalen-1-yl-(1- butylindol-3-yl)methanone);
(6) JWH-081 (4-methoxynaphthalen-1-yl- (1-pentylindol-3-yl)methanone);
(7) JWH-098 (4-methoxynaphthalen-1-yl- (1-pentyl-2-methylindol-3-yl)methanone);
(8) JWH-122 (1-pentyl-3-(4-methyl-1- naphthoyl)indole);
(9) JWH-164 (7-methoxynaphthalen-1-yl- (1-pentylindol-3-yl)methanone;
(10) JWH-200 (1-(2-morpholin-4- ylethyl)indol-3-yl)-naphthalen-1-ylmethanone);
(11) JWH-203 (2-(2-chlorophenyl)-1-(1- pentylindol-3-yl)ethanone;
(12) JWH-210 (4-ethylnaphthalen-1-yl-(1- pentylindol-3-yl)methanone;
(13) JWH-250 (1-pentyl-3-(2- methoxyphenylacetyl)indole);
(14) JWH-251 (1-pentyl-3-(2- methylphenylacetyl)indole);
(15) JWH-398 (1-pentyl-3-(4-chloro-1- naphthoyl)indole);
(16) HU-210 ((6aR,10aR)-9- (Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2- yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol);
(17) HU-211 ((6aS,10aS)-9- (Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2- yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol);
(18) HU-308 ([(lR,2R,5R)-2-[2,6- dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7- dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol);
(19) HU-331 ((3-hydroxy-2-[(1R,6R)-3- methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5- pentyl-2,5-cyclohexadiene-1,4-dione);
(20) CP 55,940 (2-[(1R,2R,5R)-5-hydroxy- 2-(3-hydroxypropyl) cyclohexyl]- 5-(2-methyloctan- 2-yl)phenol);
(21) CP 47,497 (2-[(1R,3S)-3- hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol) and its homologues;
(22) WIN 55,212-2 ((R)-(+)-[2,3-Dihydro- 5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de)-1,4-benzoxazin-6-yl]-1- nepthalenylmethanone);
(23) RCS-4 ((4-methoxyphenyl)(1-pentyl- 1H-indol-3-yl)methanone);
(24) RCS-8 (1-(1-(2-cyclohexylethyl)- 1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone).
SYNTHETIC STIMULANT. Any compound which is a federally controlled Schedule I substance such as cathinone, methcathinone, MDMA and MDEA, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance which have a stimulant effect on the central nervous system. Upon banning, any of the following substances or substances which contain the described characteristics shall be considered a SYNTHETIC STIMULANT:
(1) 3-Fluoromethcathinone;
(2) 4-Fluoromethcathinone (other name: flephedrone);
(3) 3,4-Methylenedioxymethcathinone (other name: methylone, MDMC);
(4) 3,4-Methylenedioxypyrovalerone (other name: MDPV);
(5) 4-Methylmethcathinon (other names: mephedrone, 4-MMC);
(6) 4-Methoxymethcathinone (other names: methedrone, bk-PMMA, PMMC);
(7) 4-Ethylmethcathinone (other name: 4- EMC);
(8) Ethcathinone;
(9) Beta-keto-N- methylbenzodioxyolylpropylamine (other names: butylone, bk-MBDB);
(10) Napthylpyrovalerone (other names: naphyrone, NRG-1);
(11) N,N-dimethylcathinone (other name: metamfepramone);
(12) Alpha-pyrrolidinopropiophenone (other name: alpha-PPP);
(13) 4-methoxy-alpha- pyrrolidinopropiophenone (other name: MOPPP);
(14) 3,4-methylenedioxy-alpha- pyrrolidinopropiophenone (other name: MDPPP);
(15) Alpha-pyrrolidinovalerophenone (other name: alpha-PVP);
(16) 6,7-kihydro-5H-indeno(5,6-d)-1,3- dioxal-6-amine) (other name: MDAI);
(17) Any compound that is structurally derived from 2-amino-1-phenyl-1-propanone by modification or substitution in any of the following ways:
(a) In the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(b) At the 3-position with an alkyl substituent;
(c) At the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups;
(d) Or by inclusion of the nitrogen atom in a cyclic structure.
(Ord. O-2012.01, passed 3-13-2012)